2012
DOI: 10.1016/j.pharma.2012.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Exploration biologique des drogues illicites et des médicaments psychotropes en milieu professionnel

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 58 publications
0
3
0
1
Order By: Relevance
“…Polymerase chain reaction (PCR) testing is available to police to identify where specific C sativa samples came from in order to assist with forensic studies and investigations (87). In addition to urine as well as blood testing, saliva and hair testing for cannabis are possible – the latter for evaluation of chronic cannabis exposure (88, 89). …”
Section: Cannabis Lab Testingmentioning
confidence: 99%
“…Polymerase chain reaction (PCR) testing is available to police to identify where specific C sativa samples came from in order to assist with forensic studies and investigations (87). In addition to urine as well as blood testing, saliva and hair testing for cannabis are possible – the latter for evaluation of chronic cannabis exposure (88, 89). …”
Section: Cannabis Lab Testingmentioning
confidence: 99%
“…Quoi qu'il en soit, ces techniques de confirmation, complexes et longues, restent du domaine du biologiste et ne seront pas abordées ici. Citons enfin l'utilisation de spots de sang séchés, obtenus par une simple piqûre au bout du doigt, faciles à transporter et à conserver, et dont l'analyse par des techniques chromatographiques couplées à la spectrométrie de masse en tandem donne des résultats très prometteurs [21]. L'utilisation de la salive, longtemps controversée du fait du risque élevé de faux positifs pour les cannabinoïdes, a béné-ficié de progrès technologiques récents et sa fiabilité est meilleure actuellement [22,23].…”
Section: Aspects Techniquesunclassified
“…This is particularly frustrating because of the current lack of a common framework or established guidelines regarding the use of BDZ in the workplaces (Brcak et al, 2018 ; Kowalski-McGraw et al, 2018 ; Nkyekyer et al, 2018 ), and/or optimum prescribing practice that may minimize their adverse impact on an individual's injury risk. For example, even in countries whose legislation on health and safety at work does include workplace drug testing, BDZ are usually not included in the screening tests (Kazanga et al, 2012 ; Mura et al, 2012 ; Rosso et al, 2017 ). However, as the common European framework requires the employer to ban drugs at work if there is a considerable danger, while the employee should be in a state that does not endanger himself or others, characterizing the actual risk of occupational injuries in BDZ users may significantly contribute to the daily practice of Occupational Physicians (Pierce, 2012 ).…”
Section: Introductionmentioning
confidence: 99%